SECTION 4
Cell and gene therapies do not fit existing frameworks for valuing, pricing, and reimbursing pharmaceuticals. In this section, Parexel experts discuss how a focus on communicating value and aligning regulatory, clinical, and market access strategies early in development could impact patient access and market success.
Contributing Experts
Stay current with novel thinking and actionable insights from our experts.
At Parexel, we deliver innovative trial designs, built on a deep understanding of the patient journey. Our Cell and Gene Therapy Center of Excellence aggregates best practices from across the development lifecycle to help our customers navigate frequently changing regulatory hurdles and accelerate the treatment journey to patients. Parexel supports sponsors to take control of their regulatory path and reduce compliance risks to deliver a faster, smarter route from proof of concept to marketing authorization.
Accelerate your cell and gene therapy development and maximize the chances of market success with Parexel.